RPG Life Sciences Limited (NSE:RPGLIFE)
2,354.80
+9.70 (0.41%)
Oct 24, 2025, 3:30 PM IST
RPG Life Sciences Market Cap
RPG Life Sciences has a market cap or net worth of 38.95 billion as of October 24, 2025. Its market cap has decreased by -11.36% in one year.
Market Cap
38.95B
Enterprise Value
36.71B
Revenue
6.66B
Ranking
n/a
PE Ratio
18.08
Stock Price
2,354.80
Market Cap Chart
Since June 10, 2008, RPG Life Sciences's market cap has increased from 645.16M to 38.95B, an increase of 5,936.64%. That is a compound annual growth rate of 26.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 38.95B | 7.80% |
| Dec 31, 2024 | 36.13B | 63.53% |
| Dec 29, 2023 | 22.09B | 57.71% |
| Dec 30, 2022 | 14.01B | 37.00% |
| Dec 31, 2021 | 10.23B | 67.61% |
| Dec 31, 2020 | 6.10B | 18.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.08T |
| Divi's Laboratories | 1.75T |
| Cipla | 1.28T |
| Apollo Hospitals Enterprise | 1.13T |
| Zydus Lifesciences | 1.01T |
| Mankind Pharma | 1.00T |
| Fortis Healthcare | 783.12B |
| Alkem Laboratories | 662.99B |